NCT03436524View on ClinicalTrials.gov

A Prognostic Tool for Early Stage CLL

CompletedOBSERVATIONAL
Enrollment

4,933

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

February 28, 2020

Study Completion Date

February 28, 2020

Conditions
Chronic Lymphocytic Leukemia
Trial Locations (1)

28100

Azienda Ospedaliera Universitaria Maggiore della Carità, Novara

All Listed Sponsors
collaborator

Azienda Ospedaliero Universitaria Maggiore della Carita

OTHER

lead

Oncology Institute of Southern Switzerland

OTHER

NCT03436524 - A Prognostic Tool for Early Stage CLL | Biotech Hunter | Biotech Hunter